Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GFL Environmental Inc. Subordinate voting shares no par value (GFL) vs GeneDx Holdings Corp (WGS) Price & Performance

GFL Environmental Inc. Subordinate voting shares no par valueTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

GFL Environmental Inc. Subordinate voting shares no par value vs GeneDx Holdings Corp — how do they compare? GFL Environmental Inc. Subordinate voting shares no par value trades at $42.14 (market cap $18.46B), while GeneDx Holdings Corp trades at $68.95 (market cap $2.02B). The key difference: GFL Environmental Inc. Subordinate voting shares no par value is far larger — about 9.1× GeneDx Holdings Corp's market cap, and GFL Environmental Inc. Subordinate voting shares no par value pays a 0.16% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold GFL Environmental Inc. Subordinate voting shares no par value for 0 Days and GeneDx Holdings Corp for 19 Days on average.

GFLWGS
Market Cap
$18.46B$2.02B
Volume
2,438,353734,640
Sector
IndustrialsHealth
52-Week High
$46.51$167.51
52-Week Low
$33.54$34.51
Typical Hold Time
0 Days19 Days
Enterprise Value
$25.43B$2.05B
Dividend Yield
0.16%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

GFL Environmental Inc. Subordinate voting shares no par value

No Aura AI signal available yet.

GeneDx Holdings Corp

GeneDx Holdings Corp. (WGS) trades at $68.53, down 4.18% on the day, with a bearish technical signal from moving averages but oversold RSI readings. The company reported a net loss of $21.02 million for 2025, though Q2 2026 earnings beat expectations. Revenue growth is positive, but profitability remains a challenge with negative margins. Analyst consensus is strongly bullish with a $81.00 price target, supported by recent product launches and institutional interest.

The outlook hinges on execution toward profitability amid high cash burn. Investment opportunity lies in the genomic testing market expansion and analyst optimism, but risks include sustained losses, competitive pressure, and reliance on financing. The stock's trajectory will depend on achieving projected margin improvements and revenue scalability.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GFL
100% Buy0% Sell
Avg holding period · 0 Days
WGS
53% Buy47% Sell
Avg holding period · 19 Days

About GFL Environmental Inc. Subordinate voting shares no par value

GFL Environmental provides environmental services across Canada and the United States. Its operations include solid waste management and other waste and environmental solutions.

Read more on GFL →

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS →